title: Expression of COX-2, CD44v6 and CD147 and relationship with invasion and lymph node metastasis in hypopharyngeal squamous cell carcinoma.
abstract: To assess the expression of COX-2,CD44v6 and CD147 in hypopharyngeal squamous cell carcinomas and the three biomarkers correlation with tumor invasion and lymph node metastasis of Chinese people. 101 cases of surgically excised primary tumor were included in this study, and 40 tissues of epithelium adjacent to carcinoma were used as controls. We characterized the immunohistochemical expression of COX-2, CD44v6, and CD147 in 141 formalin-fixed, paraffin-embedded tissues, and measured the mean optical density (OD) of the positive area to identify the expression of the three bio-markers and relationship with tumor invasion and lymph node metastasis. Our study demonstrates that the expression of the COX-2 and CD147 were significantly increased in carcinoma tissues compared to the epithelium adjacent to carcinoma. We also observed that the expression of COX-2, CD44v6, and CD147 were significantly associated with T classification, lymph node metastasis and clinical stage. There was strong significant correlation among the three biomarkers as well. Additionally, we indicated that recurrence and ≥ P50 level of COX-2 expression had an independent prognostic effect on prognosis. In conclusion, the three biomarkers play important roles in tumor invasion and lymph node metastases and might be valuable indicators of tumor metastasis in hypopharyngeal squamous cell carcinoma.
authors.affiliation: Department of Otorhinolaryngology-Head and Neck Surgery, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, PR China.
authors.forename: Qing
authors.initials: Q
authors.lastname: Yang
authors.forename: Yehai
authors.initials: Y
authors.lastname: Liu
authors.forename: Yang
authors.initials: Y
authors.lastname: Huang
authors.forename: Dake
authors.initials: D
authors.lastname: Huang
authors.forename: Yifan
authors.initials: Y
authors.lastname: Li
authors.forename: Jing
authors.initials: J
authors.lastname: Wu
authors.forename: Maoli
authors.initials: M
authors.lastname: Duan
mesh_terms: D051926:Basigin / Q000276:immunology*; D014408:Biomarkers, Tumor / Q000276:immunology*; D002294:Carcinoma, Squamous Cell / Q000201:enzymology / Q000276:immunology / Q000473:pathology*; D051546:Cyclooxygenase 2 / Q000378:metabolism*; D006801:Humans; D018960:Hyaluronan Receptors / Q000276:immunology*; D007012:Hypopharyngeal Neoplasms / Q000201:enzymology / Q000276:immunology / Q000473:pathology*; D008207:Lymphatic Metastasis; D009361:Neoplasm Invasiveness; D016019:Survival Analysis
chemical_list: C497886:BSG protein, human; D014408:Biomarkers, Tumor; C112697:CD44v6 antigen; D018960:Hyaluronan Receptors; D051926:Basigin; D051546:Cyclooxygenase 2
references.citation: Auris Nasus Larynx. 2004 Mar;31(1):35-41
references.pmid: 15041052
references.citation: Cancer Immunol Immunother. 1996 Dec;43(4):245-53
references.pmid: 9003471
references.citation: Pol J Pathol. 2002;53(1):17-24
references.pmid: 12014221
references.citation: Oncol Rep. 2009 Oct;22(4):745-55
references.pmid: 19724852
references.citation: J Biol Chem. 2001 Jun 15;276(24):20809-12
references.pmid: 11320076
references.citation: Int J Oral Maxillofac Surg. 1997 Aug;26(4):280-3
references.pmid: 9258720
references.citation: Cancer Res. 2004 Nov 1;64(21):8126-9
references.pmid: 15520225
references.citation: Acta Histochem. 2011 Feb;113(2):131-6
references.pmid: 19836060
references.citation: Am J Clin Pathol. 2002 Jul;118(1):67-72
references.pmid: 12109858
references.citation: Histopathology. 2012 Apr;60(5):793-803
references.pmid: 22320715
references.citation: J Oral Maxillofac Surg. 2007 Sep;65(9):1725-33
references.pmid: 17719389
references.citation: Eur J Cancer. 1998 Dec;34(14 Spec No):2154-61
references.pmid: 10070281
references.citation: Laryngoscope. 2008 Aug;118(8):1362-71
references.pmid: 18496152
references.citation: Gastroenterology. 1994 Oct;107(4):1183-8
references.pmid: 7926468
references.citation: J Natl Cancer Inst. 2008 Mar 19;100(6):421-7
references.pmid: 18334709
references.citation: Anticancer Res. 2002 Jul-Aug;22(4):2089-96
references.pmid: 12174888
references.citation: Histopathology. 2009 Nov;55(5):564-75
references.pmid: 19912362
references.citation: Mod Pathol. 2005 Jan;18(1):153-60
references.pmid: 15272284
references.citation: Oral Maxillofac Surg. 2010 Mar;14(1):53-7
references.pmid: 19821125
references.citation: Laryngoscope. 2003 Aug;113(8):1406-10
references.pmid: 12897567
references.citation: Hum Pathol. 2002 Jul;33(7):708-14
references.pmid: 12196922
references.citation: J Exp Clin Cancer Res. 2011 Mar 07;30:27
references.pmid: 21385353
references.citation: J Cancer Res Clin Oncol. 2004 Jun;130(6):334-8
references.pmid: 14872339
references.citation: J Cancer Res Clin Oncol. 2010 Aug;136(8):1283-92
references.pmid: 20157733
references.citation: Cancer Res. 2007 Jan 1;67(1):9-15
references.pmid: 17210677
references.citation: PLoS One. 2008;3(10):e3360
references.pmid: 18852874
references.citation: Biochim Biophys Acta. 2000 Mar 27;1470(2):M69-78
references.pmid: 10722929
references.citation: J Oral Pathol Med. 2009 Jul;38(6):518-23
references.pmid: 19473445
references.citation: Am J Pathol. 2001 Jun;158(6):1921-8
references.pmid: 11395366
references.citation: Arch Otolaryngol Head Neck Surg. 2002 Apr;128(4):393-7
references.pmid: 11926913
references.citation: Lancet. 1995 Mar 11;345(8950):615-9
references.pmid: 7534855